Panoramic Investment Advisors »

Celldex Therapeutics shares owned by Panoramic Investment Advisors

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Panoramic Investment Advisors from 13F filings

Historical chart of Panoramic Investment Advisors investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Panoramic Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Panoramic Investment Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $206k 6.5k 31.72
2024-09-30 $221k 6.5k 33.99
2024-03-31 $273k 6.5k 41.97
2023-12-31 $258k 6.5k 39.66
2022-12-31 $290k 6.5k 44.57

More positions owned by Panoramic Investment Advisors

Spdr Series Trust State Street Spd (SPYM)
Vanguard Malvern Fds Core-plus Bd Etf (VPLS)
Schwab Strategic Tr Us Lcap Va Etf (SCHV)
Vanguard Index Fds Growth Etf (VUG)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Ishares Tr Ultra Short Dur (ICSH)
Alphabet Cap Stk Cl C (GOOG)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Dimensional Etf Trust Us Large Cap Val (DFLV)
Vanguard Whitehall Fds High Div Yld (VYM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Select Sector Spdr Tr State Street Ene (XLE)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Vaneck Etf Trust Mrngstr Wde Moat (MOAT)
Ishares Tr Core S&p500 Etf (IVV)

View all positions for Panoramic Investment Advisors

Top funds holding Celldex Therapeutics

Wellington Management Company
Kynam Capital Management
BlackRock
FMR
Vanguard Group
Bellevue Group
State Street Corporation
Point72 Asset Management
Vanguard Capital Management
Commodore Capital
Geode Capital Management
Eventide Asset Management
Eversept Partners
Braidwell
Deep Track Capital

View all funds holding Celldex Therapeutics